These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
332 related articles for article (PubMed ID: 21892124)
21. [Enterohemorrhagic Escherichia coli in hemolytic uremic syndrome in Chilean children. Evaluation of different technics in the diagnosis of the infection]. Prado V; Cordero J; Garreaud C; Olguin H; Arellano C; Nachar CL; Misraji A; Martínez J; Tous M; Rivas M Rev Med Chil; 1995 Jan; 123(1):13-22. PubMed ID: 7569441 [TBL] [Abstract][Full Text] [Related]
22. Surveillance of hemolytic uremic syndrome in children less than 15 years of age, a system to monitor O157 and non-O157 Shiga toxin-producing Escherichia coli infections in France, 1996-2006. Espié E; Grimont F; Mariani-Kurkdjian P; Bouvet P; Haeghebaert S; Filliol I; Loirat C; Decludt B; Minh NN; Vaillant V; de Valk H Pediatr Infect Dis J; 2008 Jul; 27(7):595-601. PubMed ID: 18520972 [TBL] [Abstract][Full Text] [Related]
23. Effect of early fosfomycin treatment on prevention of hemolytic uremic syndrome accompanying Escherichia coli O157:H7 infection. Ikeda K; Ida O; Kimoto K; Takatorige T; Nakanishi N; Tatara K Clin Nephrol; 1999 Dec; 52(6):357-62. PubMed ID: 10604643 [TBL] [Abstract][Full Text] [Related]
24. Disease severity of Shiga toxin-producing E. coli O157 and factors influencing the development of typical haemolytic uraemic syndrome: a retrospective cohort study, 2009-2012. Launders N; Byrne L; Jenkins C; Harker K; Charlett A; Adak GK BMJ Open; 2016 Jan; 6(1):e009933. PubMed ID: 26826153 [TBL] [Abstract][Full Text] [Related]
25. Cluster of hemolytic-uremic syndrome caused by Shiga toxin-producing Escherichia coli O26:H11. Misselwitz J; Karch H; Bielazewska M; John U; Ringelmann F; Rönnefarth G; Patzer L Pediatr Infect Dis J; 2003 Apr; 22(4):349-54. PubMed ID: 12690276 [TBL] [Abstract][Full Text] [Related]
26. Clinical course and the role of shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997-2000, in Germany and Austria: a prospective study. Gerber A; Karch H; Allerberger F; Verweyen HM; Zimmerhackl LB J Infect Dis; 2002 Aug; 186(4):493-500. PubMed ID: 12195376 [TBL] [Abstract][Full Text] [Related]
27. A cluster of Escherichia coli O157:H7 infections with the hemolytic-uremic syndrome and death in California. A mandate for improved surveillance. Shefer AM; Koo D; Werner SB; Mintz ED; Baron R; Wells JG; Barrett TJ; Ginsberg M; Bryant R; Abbott S; Griffin PM West J Med; 1996; 165(1-2):15-9. PubMed ID: 8855679 [TBL] [Abstract][Full Text] [Related]
29. Risk of hemolytic uremic syndrome after sporadic Escherichia coli O157:H7 infection: results of a Canadian collaborative study. Investigators of the Canadian Pediatric Kidney Disease Research Center. Rowe PC; Orrbine E; Lior H; Wells GA; Yetisir E; Clulow M; McLaine PN J Pediatr; 1998 May; 132(5):777-82. PubMed ID: 9602185 [TBL] [Abstract][Full Text] [Related]
30. E. coli, antibiotics and hemolytic-uremic syndrome in children. Farquhar D CMAJ; 2000 Aug; 163(4):438. PubMed ID: 10976267 [No Abstract] [Full Text] [Related]
31. [The epidemiology of human enterohemorrhagic Escherichia coli infections in Lower Saxony]. Dreesman J; Pulz M Dtsch Tierarztl Wochenschr; 2004 Aug; 111(8):317-20. PubMed ID: 15469059 [TBL] [Abstract][Full Text] [Related]
32. Need for long-term follow-up in enterohemorrhagic Escherichia coli-associated hemolytic uremic syndrome due to late-emerging sequelae. Rosales A; Hofer J; Zimmerhackl LB; Jungraithmayr TC; Riedl M; Giner T; Strasak A; Orth-Höller D; Würzner R; Karch H; Clin Infect Dis; 2012 May; 54(10):1413-21. PubMed ID: 22412065 [TBL] [Abstract][Full Text] [Related]
33. Risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. O'Ryan M; Prado V N Engl J Med; 2000 Oct; 343(17):1271; author reply 1272-3. PubMed ID: 11183358 [No Abstract] [Full Text] [Related]
34. [Retrospective analysis of the relationship between HUS incidence and antibiotics among patients with Escherichia coli O157 enterocolitis in the Sakai outbreak]. Higami S; Nishimoto K; Kawamura T; Tsuruhara T; Isshiki G; Ookita A Kansenshogaku Zasshi; 1998 Mar; 72(3):266-72. PubMed ID: 9643979 [TBL] [Abstract][Full Text] [Related]
35. Albuminuria and estimated GFR 5 years after Escherichia coli O157 hemolytic uremic syndrome: an update. Garg AX; Salvadori M; Okell JM; Thiessen-Philbrook HR; Suri RS; Filler G; Moist L; Matsell D; Clark WF Am J Kidney Dis; 2008 Mar; 51(3):435-44. PubMed ID: 18295059 [TBL] [Abstract][Full Text] [Related]
36. Does blood type B protect against haemolytic uraemic syndrome? An analysis of the 1996 Sakai outbreak of Escherichia coli O157:H7 (VTEC O157) infection. The Osaka HUS Critical Care Study Group. Shimazu T; Shimaoka M; Sugimoto H; Taenaka N; Hasegawa T J Infect; 2000 Jul; 41(1):45-9. PubMed ID: 10942639 [TBL] [Abstract][Full Text] [Related]
37. A role for fosfomycin treatment in children for prevention of haemolytic-uraemic syndrome accompanying Shiga toxin-producing Escherichia coli infection. Tajiri H; Nishi J; Ushijima K; Shimizu T; Ishige T; Shimizu M; Tanaka H; Brooks S Int J Antimicrob Agents; 2015 Nov; 46(5):586-9. PubMed ID: 26391378 [TBL] [Abstract][Full Text] [Related]